Best Cancer Screening Tests in 2026

Traditional screening tests (mammograms, colonoscopies, PSA tests) look for one specific cancer each. Galleri analyzes cell-free DNA in blood to detect signals from 50+ cancer types, including many without standard screening tests. Galleri supplements rather than replaces traditional screening. Its strength is finding cancers that would otherwise be detected only after symptoms appear, often at later stages.

In GRAIL's CCGA validation study, Galleri detected 51.5% of cancers overall, rising with stage from 16.8% at stage I to 90.1% at stage IV, with 99.5% specificity (Klein et al., Ann Oncol 2021). In the PATHFINDER 2 study of 32,007 adults aged 50 and older, it detected 39.3% of cancers diagnosed within a year, with 99.64% specificity (Nabavizadeh et al., Nat Med 2026). For specific cancers, traditional screening may be more sensitive, but MCED catches cancers that lack any screening option. No test catches everything, and negative results don't guarantee you're cancer-free.

People at elevated cancer risk due to age (50+), family history, or genetic predisposition may benefit most. Those with access to timely follow-up care get more value since positive results require additional testing. MCED tests are not recommended as the only screening approach since they complement but don't replace colonoscopy, mammography, and other proven screens. Cost and insurance coverage also factor into the decision.

A positive result triggers additional diagnostic testing to locate and confirm the cancer. MCED tests predict the likely cancer origin, but imaging and potentially biopsy confirm the finding. This process may involve weeks of uncertainty and multiple appointments. In PATHFINDER 2, 60.3% of positive Galleri results led to a cancer diagnosis, so about 4 in 10 positive results did not (Nabavizadeh et al., Nat Med 2026). Discuss the implications with your doctor before testing.

Coverage varies significantly. Cologuard for colorectal screening is widely covered. Newer MCED tests like Galleri typically aren't covered by insurance or Medicare. Some employers and concierge medicine practices include them in health benefits. Galleri lists at $949 without coverage. As clinical evidence accumulates, coverage is expected to expand over the next several years.